RecruitingNCT06059053
Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.
Sponsor
University Hospital Muenster
Enrollment
100 participants
Start Date
Jan 12, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this registry is to evaluate the semibranch in branched endovascular aortic repair, which is a new tool in endovascular branched aortic repair.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Semibranch CMD branched aortic stentgraft for people with aortic aneurysm, endovascular aortic repair, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICESemibranch CMD branched aortic stentgraft
bEVAR with a custom made abdominal aortic multibranch, which incorporates the semibranch design
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06059053
Related Trials
Laser In Situ Fenestration Study
NCT064119901 location
Cerebral Protection in Aortic Arch Surgery
NCT04966247
Exoskeleton vs. Standard Lead Apron in EVAR Procedures
NCT075281441 location
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
NCT0707838321 locations
Prospective Evaluation of Physician Modified Endografts for Aortic Disease
NCT076119681 location